DSE/SAMORITA (DSE/SAMORITA)

Dhaka Stock Exchange: DSE/SAMORITA · BDT

BDT 84.7

-1.40 (-1.6%)· Recorded snapshot

Market cap	1.8B
Revenue (ttm)	426.6M
Net income (ttm)	10.7M
EPS (ttm)	BDT 0.49
Shares out	21.8M
P/E (trailing)	172.1x
Dividend	BDT 0.50 (0.59%)
Volume	111,684
Beta	-0.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 426.6M
Net income (ttm): 10.7M
EPS (ttm): BDT 0.49
P/E (trailing): 172.1x
Market cap: 1.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E172.1

P25 n/aP50 n/aP75 n/a

ROE1

P25 n/aP50 n/aP75 n/a

ROIC0.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/SAMORITA indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

BDT

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2027-01-25
Employees	578
Employees change	19
Employees growth	3.4%
Enterprise value	BDT 1.8B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	June
Founded	1984
Industry	Hospitals
Is primary listing	Yes
ISIN number	BD0553SMHOS8
Last earnings date	2026-04-25
Last refreshed	2026-10-29
Last stock split date	2023-12-10
Last stock split type	Forward
Market cap	BDT 1.8B
Next earnings date	2027-01-25
Price	BDT 84.70
Price currency	BDT
SIC code	8060
Stock price date	2026-10-29
Symbol	dse/SAMORITA
Website	https://samoritahospital.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	171.18x
Average P/E ratio (3Y)	293.21x
Average P/E ratio (5Y)	290.35x
Earnings yield	0.58%
EV/Earnings	165.12x
EV/EBIT	96.47x
EV/EBITDA	40.94x
EV/FCF	88.57x
EV/Sales	4.15x
FCF / EV yield	1.13%
FCF yield	1.08%
Graham number	23.21386
Graham upside	-73.04%
Lynch fair value	BDT 2.46
Lynch upside	-97.14%
P/B ratio	1.74x
P/E ratio	172.1x
P/FCF ratio	92.31x
P/OCF ratio	40.07x
P/S ratio	4.33x
Price / tangible book value	1.74x
Price/EBITDA ratio	43.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.28%
EBITDA margin	9.9%
Effective tax rate	49.24%
FCF margin	4.69%
Gross margin	58.11%
Operating margin	4.28%
Pretax margin	4.95%
Profit margin	2.52%
Profit per employee	BDT 18,563
Revenue per employee	BDT 738,020
ROA	0.94%
ROA (5Y)	1.25%
ROCE	1.59%
ROE	1.01%
ROE (5Y)	1.74%
ROIC	0.91%
ROIC (5Y)	1.72%
Tax / revenue	2.44%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-9.45%
EPS growth 10Y	-12.55%
EPS growth 3Y	123.03%
EPS growth 5Y	-0.06%
FCF growth	272.24%
FCF growth (Q)	2,510.7%
Gross profit growth	16.99%
Gross profit growth (Q)	67.37%
Gross profit growth 3Y	12.32%
Gross profit growth 5Y	6.6%
Net income growth	-7.83%
Net income growth 3Y	124.35%
Net income growth 5Y	0.29%
OCF growth	72.02%
OCF growth (Q)	750.64%
OCF growth 10Y	-4.07%
OCF growth 3Y	9.22%
OCF growth 5Y	7.15%
Operating income growth	51.09%
Operating income growth 3Y	58.42%
Operating income growth 5Y	12.87%
Revenue growth	9.15%
Revenue growth (Q)	18.13%
Revenue growth (QoQ)	48.33%
Revenue growth 10Y	1.61%
Revenue growth 3Y	10.36%
Revenue growth 5Y	5.18%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -26.1M
Depreciation and amortization	BDT 24.1M
EBIT	BDT 18.2M
EBITDA	BDT 42.2M
EPS	BDT 0.49
FCF per share	BDT 0.92
Financing cash flow	BDT -17.9M
Free cash flow	BDT 20M
Gross profit	BDT 247.9M
Income taxes	BDT 10.4M
Investing cash flow	BDT -21.3M
Net borrowing	BDT -7.4M
Net cash flow	BDT 6.9M
Net income	BDT 10.7M
Operating income	BDT 18.2M
Revenue	BDT 426.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.31
Book value per share	BDT 48.67
Debt / EBITDA	0.09
Debt / equity	0
Debt / FCF	0.2
Interest coverage	7.4
Long-term assets	BDT 1.1B
Long-term liabilities	BDT 63.8M
Net cash (debt)	BDT 44M
Net cash / market cap	2.38%
Net cash growth	106.57%
Net debt / EBITDA	-1.04
Net debt / equity	-0.04
Net debt / FCF	-2.2
Piotroski F-Score	6
Property, plant and equipment	BDT 1.1B
Shareholders' equity	BDT 1.1B
Tangible book value	BDT 1.1B
Tangible book value per share	BDT 48.67
Total assets	BDT 1.2B
Total cash	BDT 47.9M
Total debt	BDT 3.9M
Total liabilities	BDT 152.9M
WACC	3.69%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.35
Current assets	BDT 143M
Current liabilities	BDT 89.1M
Current ratio	1.57
Inventory turnover	8.39
Net working capital	BDT -9.9M
Quick ratio	0.89
Working capital	BDT 37.5M
Working capital turnover	9.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.79%
Dividend growth	100%
Dividend growth (10Y)	2.92%
Dividend growth (3Y)	30.06%
Dividend growth (5Y)	2.92%
Dividend growth years	0
Dividend payment date	2027-01-26
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	BDT 0.50
Dividend yield	0.59%
Ex-dividend date	2026-11-18
FCF payout ratio	108.99%
Last dividend	BDT 1.00
Payout ratio	101.6%
Shareholder yield	-1.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	78.07%
10Y return CAGR	6.93%
10Y total return	95.39%
150-day SMA	BDT 83.39
15Y price change	143.41%
15Y return CAGR	7.11%
15Y total return	180.14%
1D price change	-1.63%
1M price change	-9.31%
1M total return	-9.31%
1W price change	-2.64%
1W total return	-2.64%
1Y price change	15.24%
1Y return CAGR	16.09%
1Y total return	16.07%
20-day SMA	BDT 87.38
200-day SMA	BDT 80.03
20Y price change	1,353.33%
20Y return CAGR	16.01%
20Y total return	1,849.62%
3M price change	-11.77%
3M total return	-11.77%
3Y price change	22.27%
3Y return CAGR	7.52%
3Y total return	24.31%
50-day SMA	BDT 93.44
50-day SMA vs 200-day SMA	50over200
52-week high	BDT 120.00
52-week high date	2026-08-23
52-week low	BDT 63.00
52-week low date	2025-11-16
5Y price change	16.19%
5Y return CAGR	3.79%
5Y total return	20.42%
6M price change	21%
6M total return	21%
All-time high	BDT 120.00
All-time high date	2026-08-23
All-time low	BDT 1.77
All-time low date	1998-05-27
Average true range (ATR)	BDT 4.39
Average volume	196.5K
Beta (1Y)	0.3
Beta (2Y)	0.15
Beta (5Y)	-0.11
Change from 52-week high	-29.42%
Change from 52-week low	34.44%
Change from all-time high	-29.42%
Change from all-time low	4,696.15%
Dollar volume	BDT 9.5M
High price	BDT 86.40
Low price	BDT 84.00
Monthly RSI	57.3
Position in 52-week range	29.17%
Previous close	BDT 86.10
Price vs 150-day SMA	1.57%
Price vs 20-day SMA	-3.06%
Price vs 200-day SMA	5.83%
Price vs 50-day SMA	-9.36%
Relative volume	0.55
RSI	42.4
Sharpe ratio	0.41
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	0.23
Sortino ratio	0.81
Sortino ratio (3Y)	0.68
Sortino ratio (5Y)	0.53
Volume	111.7K
Weekly RSI	97.9
YTD price change	18.46%
YTD total return	18.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	-4.08%
Shares change (YoY)	1.79%
Shares outstanding	21.8M

Deeper analysis on DSE/SAMORITA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/SAMORITA report

Is a complete DSE/SAMORITA research report available?

No complete published report is available for dse/SAMORITA (DSE/SAMORITA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/SAMORITA (DSE/SAMORITA)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/SAMORITA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/SAMORITA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/SAMORITA

Frequently asked questions